MFDS
- Status: likely_approved
🇰🇷 Ultomiris in South Korea
Ultomiris (RAVULIZUMAB) regulatory status in South Korea.
Marketing authorisation
Ultomiris in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in South Korea
Frequently asked questions
Is Ultomiris approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Ultomiris in South Korea?
AstraZeneca is the originator. The local marketing authorisation holder may differ — check the official source linked above.